Literature DB >> 1974829

Enhanced preneoplastic liver lesion development under 'selection pressure' conditions after administration of deoxycholic or lithocholic acid in the initiation phase in rats.

S Kitazawa1, A Denda, M Tsutsumi, T Tsujiuchi, K Hasegawa, K Tamura, H Maruyama, Y Konishi.   

Abstract

The initiating potential of the secondary bile acids, deoxycholic acid (DCA) and lithocholic acid (LCA), for rat hepatocarcinogenesis was investigated using the development of hyperplastic nodules and/or glutathione S-transferase placental form (GST-P)-positive liver foci as the end point. Five week old male F344 rats were given either basal diet, or diets containing 0.5% DCA or 0.5% LCA for 3 weeks in conjunction with partial hepatectomy performed midway, followed by a selection regimen consisting of 2 weeks feeding of 0.02% 2-acetylaminofluorene diet and a single gastric intubation of carbon tetrachloride. The animals were then placed on either basal diet or a diet containing 0.05% phenobarbital (PB) for 52 weeks. Significantly higher numbers of hyperplastic liver nodules developed in the DCA-treated rats irrespective of PB promotion as compared with the respective control groups. No such increase was evident in the LCA-treated rats. In contrast, both DCA and LCA treatments enhanced the development of GST-P-positive liver foci with or without subsequent PB promotion. Only one hepatocellular carcinoma was diagnosed in a control group animal. The present data indicate that a short period of feeding of DCA and LCA in the initiation stage in conjunction with partial hepatectomy results in enhanced development of preneoplastic liver lesions under selection pressure conditions with or without subsequent PB promotion. They thus confirm and extend our previous finding of enhanced gamma-glutamyltranspeptidase-positive liver foci development in a short-term assay of DCA and LCA, and suggest that these secondary bile acids either possess possible initiating activity or some other priming effect for rat hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974829     DOI: 10.1093/carcin/11.8.1323

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

Review 1.  Microbiome and cancer.

Authors:  Naoko Ohtani
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

2.  Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.

Authors:  Shin Yoshimoto; Tze Mun Loo; Koji Atarashi; Hiroaki Kanda; Seidai Sato; Seiichi Oyadomari; Yoichiro Iwakura; Kenshiro Oshima; Hidetoshi Morita; Masahira Hattori; Masahisa Hattori; Kenya Honda; Yuichi Ishikawa; Eiji Hara; Naoko Ohtani
Journal:  Nature       Date:  2013-06-26       Impact factor: 49.962

Review 3.  Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics.

Authors:  Nina Frey; Sascha Venturelli; Lars Zender; Michael Bitzer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-29       Impact factor: 46.802

Review 4.  Role of the microbiome in non-gastrointestinal cancers.

Authors:  Meirav Pevsner-Fischer; Timur Tuganbaev; Mariska Meijer; Sheng-Hong Zhang; Zhi-Rong Zeng; Min-Hu Chen; Eran Elinav
Journal:  World J Clin Oncol       Date:  2016-04-10

Review 5.  The influence of the commensal microbiota on distal tumor-promoting inflammation.

Authors:  Claire M Buchta Rosean; Melanie R Rutkowski
Journal:  Semin Immunol       Date:  2017-07-04       Impact factor: 11.130

6.  StemPanTox: A fast and wide-target drug assessment system for tailor-made safety evaluations using personalized iPS cells.

Authors:  Junko Yamane; Takumi Wada; Hironori Otsuki; Koji Inomata; Mutsumi Suzuki; Tomoka Hisaki; Shuichi Sekine; Hirokazu Kouzuki; Kenta Kobayashi; Hideko Sone; Jun K Yamashita; Mitsujiro Osawa; Megumu K Saito; Wataru Fujibuchi
Journal:  iScience       Date:  2022-06-06

7.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

8.  Bile acids activate YAP to promote liver carcinogenesis.

Authors:  Sayeepriyadarshini Anakk; Manoj Bhosale; Valentina A Schmidt; Randy L Johnson; Milton J Finegold; David D Moore
Journal:  Cell Rep       Date:  2013-11-21       Impact factor: 9.423

Review 9.  Gut Microbiota and Hepatocellular Carcinoma.

Authors:  Xueme Tao; Nin Wang; Wenxi Qin
Journal:  Gastrointest Tumors       Date:  2015-04-22

10.  Plasma bile acids show a positive correlation with body mass index and are negatively associated with cognitive restraint of eating in obese patients.

Authors:  Philip Prinz; Tobias Hofmann; Anne Ahnis; Ulf Elbelt; Miriam Goebel-Stengel; Burghard F Klapp; Matthias Rose; Andreas Stengel
Journal:  Front Neurosci       Date:  2015-06-03       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.